Zota Health Care (ZOTA)₹1,274+2.70%Pharmaceuticals
In the Sep 2026 quarter (consolidated), Zota Health Care reported sales of ₹199 Cr, up 54.2% from Sep 2025, and net profit of −₹26.11 Cr. For the year to Mar 2026, sales were ₹539 Cr and net profit −₹74.25 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 47.07 | 50.12 | 56.06 | 67.12 | 72.16 | 97.23 | 104 | 129 | 143 | 163 | 174 | 199 |
| Expenses | 44.05 | 51.04 | 58.03 | 68.03 | 78.05 | 95.12 | 100 | 123 | 143 | 154 | 185 | 196 |
| Operating Profit | 3.01 | −1.01 | −1.01 | −1.01 | −6.02 | 2.01 | 4.02 | 6.02 | 0.00 | 9.04 | −12.04 | 3.01 |
| OPM % | 7.0% | −3.0% | −2.2% | −1.3% | −8.0% | 2.5% | 3.8% | 4.9% | −0.3% | 5.0% | −7.1% | 1.5% |
| Other Income | 0.00 | 0.00 | 0.00 | 1.01 | 1.01 | 1.01 | 1.01 | 2.01 | 2.01 | −3.01 | 2.01 | 5.01 |
| Interest | 0.99 | 1.99 | 2.99 | 2.99 | 1.99 | 2.99 | 2.99 | 3.98 | 4.98 | 4.98 | 5.98 | 5.98 |
| Depreciation | 5.01 | 7.01 | 8.01 | 10.01 | 11.01 | 14.02 | 15.01 | 19.01 | 22.02 | 27.03 | 28.04 | 29.04 |
| Profit before tax | −3.01 | −10.02 | −12.02 | −13.03 | −18.04 | −14.04 | −13.02 | −14.03 | −26.05 | −26.07 | −44.05 | −27.06 |
| Tax % | 7.0% | −27.0% | 5.0% | −4.0% | 2.0% | −10.0% | 5.0% | 13.0% | 14.0% | −45.0% | 1.0% | −4.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −5.01 | 0.00 | 0.00 |
| Net Profit | −3.01 | −7.03 | −13.05 | −12.05 | −19.06 | −13.04 | −14.05 | −16.05 | −30.10 | −14.05 | −44.18 | −26.11 |
| EPS (Rs) | −1.15 | −2.69 | −4.80 | −4.42 | −6.79 | −4.51 | −4.82 | −5.21 | −8.75 | −4.10 | −12.60 | −7.40 |
| Mar 2015 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 56.14 | 85.17 | 95.14 | 106 | 131 | 139 | 180 | 293 | 539 | 680 |
| Expenses | 47.08 | 77.06 | 90.10 | 105 | 116 | 132 | 173 | 298 | 520 | 679 |
| Operating Profit | 8.03 | 8.03 | 5.02 | 1.01 | 15.04 | 7.02 | 8.03 | −6.02 | 19.08 | 0.01 |
| OPM % | 15.0% | 9.0% | 4.8% | 0.6% | 11.0% | 5.0% | 4.2% | −2.0% | 3.4% | 0.0% |
| Other Income | 0.00 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 | 1.01 | 2.01 | 1.01 | 6.02 |
| Interest | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 2.99 | 4.98 | 10.97 | 16.93 | 21.92 |
| Depreciation | 2.01 | 1.01 | 2.01 | 3.01 | 4.01 | 12.01 | 20.01 | 43.06 | 82.10 | 106 |
| Profit before tax | 6.01 | 8.01 | 4.01 | 0.00 | 12.03 | −5.01 | −16.03 | −58.15 | −80.20 | −123 |
| Tax % | 33.0% | 29.0% | 29.0% | −41.0% | 28.0% | 23.0% | −11.0% | −2.0% | −7.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 | 1.01 | 0.00 | 0.00 | −5.01 | −5.01 |
| Net Profit | 4.02 | 6.02 | 3.01 | 0.00 | 9.03 | −6.02 | −14.05 | −57.19 | −74.25 | −114 |
| EPS (Rs) | 2.13 | 2.27 | 1.13 | −0.10 | 3.55 | −2.30 | −5.56 | −19.75 | −21.40 | −32.85 |
| Dividend payout % | 34.0% | 32.1% | 90.0% | −1,169.9% | 42.1% | −44.0% | −17.9% | −5.0% | −5.0% | — |
| Mar 2015 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13.96 | 17.93 | 24.92 | 24.92 | 24.89 | 24.89 | 25.91 | 28.91 | 34.87 |
| Reserves | 4.02 | 51.17 | 44.16 | 42.13 | 64.26 | 55.23 | 64.26 | 196 | 661 |
| Borrowings | 4.98 | 0.00 | 0.00 | 0.00 | 14.94 | 44.82 | 94.71 | 139 | 269 |
| Other Liabilities | 17.04 | 20.90 | 19.90 | 18.90 | 34.93 | 33.07 | 43.06 | 75.99 | 166 |
| Total Liabilities | 40.00 | 90.00 | 87.98 | 84.95 | 139 | 158 | 228 | 439 | 1,132 |
| Fixed Assets | 8.02 | 10.03 | 15.03 | 14.02 | 29.07 | 62.10 | 103 | 185 | 370 |
| CWIP | 0.00 | 1.99 | 0.00 | 0.00 | 0.00 | 2.99 | 4.99 | 5.99 | 14.96 |
| Investments | 0.00 | 16.05 | 14.03 | 10.02 | 33.07 | 8.02 | 5.01 | 54.09 | 264 |
| Other Assets | 31.98 | 62.93 | 58.92 | 60.91 | 76.88 | 84.90 | 116 | 193 | 483 |
| Inventories | 17.99 | 32.98 | 24.99 | 28.01 | 29.02 | 41.97 | 53.99 | 106 | 193 |
| Trade receivables | 12.01 | 22.03 | 29.03 | 29.03 | 36.06 | 28.05 | 27.04 | 40.04 | 74.06 |
| Cash & equivalents | 0.00 | 2.01 | 1.01 | 1.01 | 2.01 | 1.01 | 1.01 | 4.01 | 96.36 |
| Total Assets | 40.00 | 90.00 | 87.98 | 84.95 | 139 | 158 | 228 | 439 | 1,132 |
| Mar 2015 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 5.01 | −3.01 | 6.01 | −1.01 | 13.01 | −2.01 | −6.01 | −50.07 | −82.18 |
| Cash from investing activity | −0.99 | 8.97 | −3.99 | 3.98 | −26.92 | 14.94 | −12.95 | −91.63 | −329 |
| Cash from financing activity | −4.01 | −6.01 | −3.01 | −2.01 | 14.02 | −14.03 | 19.03 | 145 | 504 |
| Net cash flow | 0.00 | −0.99 | −0.99 | 0.99 | 0.99 | −0.99 | 0.00 | 2.99 | 91.81 |
| Capex | 0.99 | 2.99 | 5.99 | 1.99 | 2.99 | 11.97 | 16.96 | 45.88 | 126 |
| Free cash flow | 3.99 | −5.99 | −0.99 | −1.99 | 9.97 | −12.98 | −22.96 | −95.88 | −208 |
| CFO / OP % | 81.0% | −12.0% | 147.0% | −134.0% | 115.0% | 2.0% | −59.0% | 811.0% | −380.0% |
| Mar 2015 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 78 | 96 | 113 | 100 | 103 | 74 | 56 | 52 | 51 |
| Inventory days | 174 | 207 | 138 | 139 | 120 | 182 | 200 | 276 | 323 |
| Days payable | 0 | 104 | 82 | 77 | 78 | 116 | 126 | 111 | 176 |
| Cash conversion cycle | 252 | 200 | 170 | 162 | 146 | 141 | 132 | 218 | 199 |
| Working capital days | 79 | 174 | 151 | 142 | 107 | 110 | 74 | 99 | 83 |
| ROCE % | 32.1% | — | 6.0% | −2.0% | 15.0% | −2.0% | −7.0% | −17.0% | −8.0% |
For the Sep 2026 quarter, Zota Health Care reported sales of ₹199 Cr, up 54.2% year on year and net profit of −₹26.11 Cr. The operating margin was 1.5%.
Zota Health Care's sales for the year to Mar 2026 were ₹539 Cr; over the last twelve months they were ₹680 Cr.
Net profit for the year to Mar 2026 was −₹74.25 Cr, and −₹114 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−32.85.
Zota Health Care reported borrowings of ₹269 Cr at Mar 2026, against cash and equivalents of ₹96.36 Cr.
Cash from operations was −₹82.18 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹208 Cr.